An additional cause of health care disparities: the variable clinical decisions of primary care doctors.

RATIONALE, AIMS AND OBJECTIVES Decades of work on health disparities have culminated in identification of three contributors to variability in diagnosis and management of disease: (i) patient attributes; (ii) doctor's characteristics; and (iii) organizational factors. Understanding the relative influence of different contributors to variability in diagnosis and management of diabetes is important to improving quality and reducing disparities. This study was designed to examine the influence of patient, provider and organizational factors on the diagnosis and management of a major chronic disease - diabetes. METHOD A factorial experiment using video vignettes was conducted among n = 192 primary care doctors. Doctors were interviewed after viewing vignettes of (1) a 'patient' with symptoms strongly suggestive of diabetes and (2) an already diagnosed diabetes 'patient' with emerging peripheral neuropathy. RESULTS A total of 60.9% of doctors identified diabetes as the correct diagnosis, with significant variations depending on the patients' race/ethnicity. Many doctors offered competing diagnoses with high levels of certainty. For the 'patient' with emerging peripheral neuropathy, 42.2% of doctors would do all essential components of a foot examination, while 21.9% would do none. CONCLUSIONS That half of all diabetes in the United States remains undiagnosed is unsurprising given only 60.9% of doctors would diagnose it when the condition is strongly suggested, and nearly one-quarter suspecting diabetes would not order tests necessary to confirm it. The diagnosis of diabetes is significantly influenced by a patient's race/ethnicity, and clinical management (specifically for foot neuropathy) is influenced by patient socio-economic status (SES), doctor's gender and access to clinical guidelines.

[1]  India U.S. Consulate Chennai U.S. Department of Health & Human Services , 2014 .

[2]  J. Mckinlay,et al.  Do Doctors Contribute to the Social Patterning of Disease , 2012, Medical care research and review : MCRR.

[3]  J. Mckinlay,et al.  The relative contribution of patient, provider and organizational influences to the appropriate diagnosis and management of diabetes mellitus. , 2011, Journal of evaluation in clinical practice.

[4]  V. Basevi Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[5]  Sara Arber,et al.  It's About Time: Physicians' Perceptions of Time Constraints in Primary Care Medical Practice in Three National Healthcare Systems , 2010, Medical care.

[6]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[7]  J. Mckinlay,et al.  The intended and unintended consequences of clinical guidelines. , 2009, Journal of evaluation in clinical practice.

[8]  J. Mckinlay,et al.  Do physicians attend to base rates? Prevalence data and statistical discrimination in the diagnosis of coronary heart disease. , 2009, Health services research.

[9]  A. Sehgal,et al.  Eliminating Healthcare Disparities in America: Beyond the IOM Report , 2008, Annals of Internal Medicine.

[10]  J. Dora,et al.  Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[11]  Silvio E. Inzucchi,et al.  Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[12]  Alan M Zaslavsky,et al.  Testing for statistical discrimination by race/ethnicity in panel data for depression treatment in primary care. , 2008, Health services research.

[13]  M. Peek,et al.  Diabetes Health Disparities , 2007, Medical care research and review : MCRR.

[14]  Peter Lindgren,et al.  Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary , 2007 .

[15]  Chris M Kozma,et al.  The National Guideline Clearinghouse. , 2006, Managed care interface.

[16]  R. Steinbrook Facing the diabetes epidemic--mandatory reporting of glycosylated hemoglobin values in New York City. , 2006, The New England journal of medicine.

[17]  E. Guadagnoli,et al.  The Influence of Physicians’ Practice Management Strategies and Financial Arrangements on Quality of Care Among Patients With Diabetes , 2004, Medical care.

[18]  B. Fleming,et al.  Variation in diabetes care among states: do patient characteristics matter? , 2002, Diabetes care.

[19]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[20]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[21]  Robert Atkins,et al.  The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. , 2002, Diabetes care.

[22]  M. Engelgau,et al.  A Diabetes Report Card for the United States: Quality of Care in the 1990s , 2002, Annals of Internal Medicine.

[23]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[24]  M. Harris,et al.  Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. , 2001, Diabetes care.

[25]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[26]  J. Mckinlay,et al.  US public health and the 21st century: diabetes mellitus , 2000, The Lancet.

[27]  Kahn Cr Diabetes: a strategic plan for the 21st century. , 1999 .

[28]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[29]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[30]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[31]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[32]  M. Harris,et al.  Undiagnosed NIDDM: Clinical and Public Health Issues , 1993, Diabetes Care.

[33]  J. Eisenberg,et al.  Physician Utilization: The State of Research About Physicians’ Practice Patterns , 1985, Medical care.

[34]  Margaret J. Robertson,et al.  Design and Analysis of Experiments , 2006, Handbook of statistics.

[35]  J. Fradkin,et al.  Confronting the urgent challenge of diabetes: an overview. , 2012, Health affairs.

[36]  J. Mckinlay,et al.  Clinical Vignettes in Health Services Research: Advantages and Limitations of Different Formats , 2012 .

[37]  Mark E. Cowen,et al.  Encyclopedia of medical decision making , 2009 .

[38]  Richard A. Williams Eliminating Healthcare Disparities in America , 2007 .

[39]  J. Eisenberg,et al.  Physician utilization: the state of research about physicians' practice patterns. , 2002, Medical care.

[40]  Adrienne Y. Stith,et al.  Unequal treatment: confronting racial and ethnic disparities in health care. , 2003 .

[41]  L Devies,et al.  Social factors , 1999, International Journal of Obesity.

[42]  A. Baron Experimental Designs , 1990, The Behavior analyst.